Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy

Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy

Novel targeted therapies for metastatic colorectal cancer are needed to personalize treatments by guiding specific biomarkers selected on the genetic profile of patients. <i>RAS</i> and <i>BRAF</i> inhibitors have been developed for patients who become unresponsive to standar...

Full description

Bibliographic Details
Main Authors:	Gerardo Rosati, Giuseppe Aprile, Alfredo Colombo, Stefano Cordio, Marianna Giampaglia, Alessandro Cappetta, Concetta Maria Porretto, Alfonso De Stefano, Domenico Bilancia, Antonio Avallone
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Biomedicines
Subjects:	metastatic colorectal cancer precision medicine <i>RAS</i> and <i>BRAF</i> inhibitors immunotherapy anti-<i>HER-2</i> <i>TRK</i> inhibitors
Online Access:	https://www.mdpi.com/2227-9059/10/5/1035

Similar Items

Molecular Susceptibility and Treatment Challenges in Melanoma
by: Kiran Kumar Kolathur, et al.
Published: (2024-08-01)

Somatic Mutations in Surgically Treated Colorectal Liver Metastases: An Overview
by: Jane Wang, et al.
Published: (2024-04-01)

Developing Models to Predict <i>BRAF</i>V600E and <i>RAS</i> Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression
by: Agnes Stephanie Harahap, et al.
Published: (2023-10-01)

Molecular genetic characteristics of colorectal cancer depending on the status of microsatellite instability
by: K. A. Oganyan, et al.
Published: (2022-06-01)

<i>NTRK</i> Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects
by: Vasiliki Siozopoulou, et al.
Published: (2021-03-01)

Comprehensive Analysis of the Expression and Clinical Significance of RAS Family Members in Non-Small Cell Lung Cancer Based on Bioinformatics Data and the A549 Cell Line Model
by: Milena Pązik, et al.
Published: (2022-12-01)

<i>NTRK</i> Fusions in 1113 Solid Tumors in a Single Institution
by: Heejin Bang, et al.
Published: (2022-06-01)

<i>KRAS</i> and <i>BRAF</i> Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study
by: Nuria Garcia-Carbonero, et al.
Published: (2020-01-01)

Indeterminate Thyroid Nodules: From Cytology to Molecular Testing
by: Paola Vignali, et al.
Published: (2023-09-01)

The role of molecular diagnostics in the choice of therapy for biliary tract cancers
by: N. V. Mitiushkina, et al.
Published: (2024-03-01)

BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in <i>BRAF</i>-Mutated Metastatic Colorectal Cancer—A Case Series Study <i>Target Therapy of</i> BRAF-<i>Mutated mCRC</i>
by: Jen-Hao Yeh, et al.
Published: (2021-12-01)

Association of DNA Promoter Methylation and <i>BRAF</i> Mutation in Thyroid Cancer
by: Farzana Jasmine, et al.
Published: (2023-03-01)

Targeting <i>BRAF</i> Activation as Acquired Resistance Mechanism to EGFR Tyrosine Kinase Inhibitors in <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer
by: Frank Aboubakar Nana, et al.
Published: (2021-09-01)

Comparative Cyto-Histological Genetic Profile in a Series of Differentiated Thyroid Carcinomas
by: Maria de Lurdes Matos, et al.
Published: (2024-01-01)

Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel
by: Thais Maloberti, et al.
Published: (2024-04-01)

Molecular Genetic Investigation of Digital Melanoma in Dogs
by: David Conrad, et al.
Published: (2022-01-01)

Comparison of Two Rapid Assays for the Detection of <i>BRAF</i> V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
by: Elodie Long-Mira, et al.
Published: (2022-03-01)

Identifying a wide range of mutations in the <i>BRAF</i> gene for prescribing targeted drugs for melanoma treatment
by: A. N. Toropovskiy, et al.
Published: (2023-03-01)

High <i>Wnt2</i> Expression Confers Poor Prognosis in Colorectal Cancer, and Represents a Novel Therapeutic Target in BRAF-Mutated Colorectal Cancer
by: Huan Liu, et al.
Published: (2023-06-01)

Misshapen Disruption Cooperates with <i>Ras<sup>V12</sup></i> to Drive Tumorigenesis
by: Du Kong, et al.
Published: (2021-04-01)

Causative Genes of Homologous Recombination Deficiency (HRD)-Related Breast Cancer and Specific Strategies at Present
by: Seigo Nakamura, et al.
Published: (2025-02-01)

Synthesis of <i>N</i>-Substituted Iminosugar <i>C</i>-Glycosides and Evaluation as Promising <i>α</i>-Glucosidase Inhibitors
by: Haibo Wang, et al.
Published: (2022-08-01)

<i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
by: Omer Abdelgadir, et al.
Published: (2025-01-01)

Soft tissue metastasis in basal cell carcinoma
by: Shrivastava Rajeev, et al.
Published: (2007-01-01)

Detection of <i>NTRK</i> Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort
by: Bart Koopman, et al.
Published: (2022-03-01)

High Frequency of <i>PIK3CA</i> Mutations in Low-Grade Serous Ovarian Carcinomas of Japanese Patients
by: Tomoka Ishibashi, et al.
Published: (2019-12-01)

Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening
by: Saif-Eldin Abedellatif, et al.
Published: (2024-08-01)

Mortality Outcome Associated with Specific <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Metastatic Colorectal Cancer Patients: A Retrospective Cohort Study
by: Omer Abdelgadir, et al.
Published: (2025-02-01)

Effect of Naturally Occurring Compounds on Fumonisin Production and <i>fum</i> Gene Expression in <i>Fusarium</i> <i>verticillioides</i>
by: Davide Ferrigo, et al.
Published: (2021-05-01)

<i>In Vitro</i> Activity of Novel Topoisomerase Inhibitors against <i>Francisella tularensis</i> and <i>Burkholderia pseudomallei</i>
by: Adam O. Whelan, et al.
Published: (2023-05-01)

The Effects of Different Doses of 3-NOP on Ruminal Fermentation Parameters, Methane Production, and the Microbiota of Lambs In Vitro
by: Tianbao Xuan, et al.
Published: (2024-08-01)

Use of Symbiotic Fungi to Reduce the Phytotoxic Effect of DCD Nitrification Inhibitors in Lettuce
by: Akbar Padash, et al.
Published: (2022-02-01)

FGF19–<i>FGFR4</i> Signaling in Hepatocellular Carcinoma
by: Aroosha Raja, et al.
Published: (2019-06-01)

Association of <i>KRAS</i> G12C Status with Age at Onset of Metastatic Colorectal Cancer
by: Marcelo Sunagua Aruquipa, et al.
Published: (2024-02-01)

Higher <i>RET</i> Gene Expression Levels Do Not Represent anAlternative <i>RET</i> Activation Mechanism in Medullary Thyroid Carcinoma
by: Chiara Mulè, et al.
Published: (2021-10-01)

Fractionation of Lycopodiaceae Alkaloids and Evaluation of Their Anticholinesterase and Cytotoxic Activities
by: Aleksandra Dymek, et al.
Published: (2021-10-01)

<i>BRAF</i> and <i>MLH1</i> Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases
by: Thais Maloberti, et al.
Published: (2022-06-01)

Polycyclic Phenol Derivatives from the Leaves of <i>Spermacoce latifolia</i> and Their Antibacterial and α-Glucosidase Inhibitory Activity
by: Shao-Bo Liu, et al.
Published: (2022-05-01)

Enhancement of Inhibitory Activity by Combining Allosteric Inhibitors Putatively Binding to Different Allosteric Sites on Cathepsin K
by: Shun Sato, et al.
Published: (2023-05-01)

Molecular features of gastrointestinal stromal tumors “wild-type” (<i>KIT/PDGFRA</i> WT)
by: N. N. Mazurenko, et al.
Published: (2023-12-01)